TipRanks
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4502 full AI Analyst Report?

Takeda Pharmaceutical Co (4502) Stock News & Sentiment

10 Followers
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care
Premium
Company Announcements
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care
24d ago
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
Premium
Company Announcements
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
1M ago
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
Premium
Ratings
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
2M ago
TAK
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
Premium
Company Announcements
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
2M ago
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
Premium
Ratings
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
2M ago
TAK
Takeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline
Premium
Company Announcements
Takeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline
2M ago
Takeda Finalizes Share Issuance for Global Employee Incentive Plan
Premium
Company Announcements
Takeda Finalizes Share Issuance for Global Employee Incentive Plan
3M ago
More JP:4502 News >

4502 News on the Web

Innovent Biologics announces expansion of global Phase 3 MarsLight-11 trial
TipRanks News
Neutral
Takeda announces FDA acceptance of zasocitinib under priority review
TipRanks News
Bullish
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care
TipRanks News
Bullish
Morgan Stanley Remains a Buy on Takeda Pharmaceutical Co (TKPHF)
TipRanks News
Bullish
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
TipRanks News
Neutral
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
TipRanks News
Bullish
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
TipRanks News
Bullish
Takeda receives FDA approval of NDA for Mimrylo
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4502’s Media Buzz Sentiment?
Currently, no data Available
What is JP:4502’s weekly average amount of articles?
In an average week, 2.75 articles about JP:4502 are published.
    What is JP:4502’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    XENEXenon
    ABTAbbott Laboratories
    BBIOBridgeBio Pharma
    BDXBecton Dickinson
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week